Jazz Pharmaceuticals JAZZ Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's total costs & expenses?
- Jazz Pharmaceuticals (JAZZ) reported total costs & expenses of $732.3M in Q1 2026.
- How has Jazz Pharmaceuticals's total costs & expenses changed year-over-year?
- Jazz Pharmaceuticals's total costs & expenses decreased by 23.2% year-over-year, from $953.7M to $732.3M.
- What is the long-term trend for Jazz Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's total costs & expenses has grown at a 12.6% compound annual growth rate (CAGR), from $2.92B to $4.7B.
- What does total costs & expenses mean?
- The sum of all money spent by the company to operate during the period.
- How do you interpret total costs & expenses?
- An increase faster than revenue growth suggests margin compression and potential operational inefficiency.
- How does total costs & expenses compare across companies?
- Standard aggregate expense metric used to derive operating margins.